Biallelic SIGMAR1 variants in early-onset distal hereditary motor neuropathy: A Japanese case series

Background Distal hereditary motor neuropathy (dHMN) is characterized by slowly progressive distal muscle weakness and amyotrophy, and it exhibits clinical overlap with Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis (ALS). Biallelic variants in SIGMAR1 , encoding sigma nonopioid intracellular receptor 1, have been linked to autosomal recessive dHMN with pyramidal features. This study investigated the clinical and genetic features of patients with dHMN associated with SIGMAR1 variants in Japan. Methods We conducted genetic screening of Japanese patients with clinically suspected inherited peripheral neuropathies using targeted gene panels and whole-exome sequencing. SIGMAR1 variants were evaluated via segregation analysis using Sanger sequencing. Detailed clinical and electrophysiological data were systematically reviewed. Results Biallelic SIGMAR1 variants, including three novel variants and one previously reported variant, were identified in six patients from five unrelated families. The genotypes comprised compound heterozygous variants in four patients and homozygous variants in two patients. All patients presented with early-onset distal muscle weakness and atrophy. Enhanced tendon reflexes and pyramidal tract signs were frequently observed, whereas bulbar or respiratory involvement was absent. Nerve conduction studies consistently revealed motor-predominant axonal neuropathy with minimal sensory involvement. Disease progression was slow, and all patients remained ambulatory for years to decades after onset. Conclusion Our findings expand the clinical and genetic spectrum of SIGMAR1 -associated disease and support its classification as dHMN rather than ALS. SIGMAR1 variants should be considered in the genetic evaluation of early-onset motor neuropathies, particularly in patients with dHMN accompanied by pyramidal features.

Authors

Institutions

Publication Details

Journal
Journal of Neuromuscular Diseases
Published
2026-08-25
DOI
https://doi.org/10.1177/22143602261477464
Primary Topic
Pharmacological Receptor Mechanisms and Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Biallelic SIGMAR1 variants in early-onset distal hereditary motor neuropathy: A Japanese case series

Yusuke Sakiyama, Takahiro Hobara, Satoshi Nozuma, Fumikazu Kojima et al.
Journal of Neuromuscular Diseases
Pharmacological Receptor Mechanisms and Effects
article

Biallelic SIGMAR1 variants in early-onset distal hereditary motor neuropathy: A Japanese case series

Yusuke Sakiyama, Takahiro Hobara, Satoshi Nozuma, Fumikazu Kojima, Shin Hisahara, Yuka Kawata, Naoki Gamo, Makoto Samukawa, Shunsuke Ogaya, Masahiro Ando, Risa Nagatomo, Motomasa Suzuki, Kento Kodama, Akiko Yoshimura, Yujiro Higuchi, Hiroshi Takashima, Shoji Tsuji, Yu Hiramatsu, Masahiro Ando, Jun Mitsui, Jun-Hui Yuan
article en

Abstract

Background Distal hereditary motor neuropathy (dHMN) is characterized by slowly progressive distal muscle weakness and amyotrophy, and it exhibits clinical overlap with Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis (ALS). Biallelic variants in SIGMAR1 , encoding sigma nonopioid intracellular receptor 1, have been linked to autosomal recessive dHMN with pyramidal features. This study investigated the clinical and genetic features of patients with dHMN associated with SIGMAR1 variants in Japan. Methods We conducted genetic screening of Japanese patients with clinically suspected inherited peripheral neuropathies using targeted gene panels and whole-exome sequencing. SIGMAR1 variants were evaluated via segregation analysis using Sanger sequencing. Detailed clinical and electrophysiological data were systematically reviewed. Results Biallelic SIGMAR1 variants, including three novel variants and one previously reported variant, were identified in six patients from five unrelated families. The genotypes comprised compound heterozygous variants in four patients and homozygous variants in two patients. All patients presented with early-onset distal muscle weakness and atrophy. Enhanced tendon reflexes and pyramidal tract signs were frequently observed, whereas bulbar or respiratory involvement was absent. Nerve conduction studies consistently revealed motor-predominant axonal neuropathy with minimal sensory involvement. Disease progression was slow, and all patients remained ambulatory for years to decades after onset. Conclusion Our findings expand the clinical and genetic spectrum of SIGMAR1 -associated disease and support its classification as dHMN rather than ALS. SIGMAR1 variants should be considered in the genetic evaluation of early-onset motor neuropathies, particularly in patients with dHMN accompanied by pyramidal features.

Journal of Neuromuscular Diseases
Kagoshima University (JP), Sapporo Medical University (JP), Children's Medical Center (IR), Oji General Hospital (JP), Aichi Developmental Disability Center (JP), The University of Tokyo (JP), International University of Health and Welfare (JP), Kindai University (JP)
Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 17%
Pharmacological Receptor Mechanisms and Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.